Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Top Cited Papers
Open Access
- 5 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (4), 1692-1700
- https://doi.org/10.1182/blood-2006-07-037077
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) can progress to multiple myeloma (MM). Although these diseases share many of the same genetKeywords
This publication has 33 references indexed in Scilit:
- The molecular classification of multiple myelomaBlood, 2006
- Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantationBlood, 2006
- Lack of CD27 in myeloma delineates different presentation and outcomeBritish Journal of Haematology, 2005
- Comparative genomic hybridisation identifies two variants of smoldering multiple myelomaBritish Journal of Haematology, 2005
- Phenotypic Heterogeneity in Multiple Myeloma FamiliesJournal of Clinical Oncology, 2005
- MGUS and Smoldering Multiple Myeloma: Update on Pathogenesis, Natural History, and ManagementHematology-American Society Hematology Education Program, 2005
- Evaluation of Multiple Models to Distinguish Closely Related Forms of Disease Using DNA Microarray Data: an Application to Multiple MyelomaStatistical Applications in Genetics and Molecular Biology, 2004
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958